Aditxt Inc
General ticker "ADTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $37.8K
Aditxt Inc does not follow the US Stock Market performance with the rate: -45.5%.
Estimated limits based on current volatility of 12.3%: low 0.19$, high 0.24$
Factors to consider:
- Current price 99.5% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [36.85$, 253.07$]
- 2024-12-30 to 2025-12-30 estimated range: [9.79$, 60.33$]
Financial Metrics affecting the ADTX estimates:
- Negative: Non-GAAP EPS, $ of -101.77 <= 0.10
- Negative: Operating profit margin, % of -97.58 <= 1.03
- Negative: Operating cash flow per share per price, % of -93.52 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term ADTX quotes
Long-term ADTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.11MM | $0.93MM | $0.65MM |
| Operating Expenses | $42.04MM | $25.87MM | $26.71MM |
| Operating Income | $-41.93MM | $-24.94MM | $-26.06MM |
| Non-Operating Income | $-4.44MM | $-2.71MM | $-6.33MM |
| Interest Expense | $1.94MM | $2.29MM | $6.39MM |
| R&D Expense | $5.04MM | $7.27MM | $7.07MM |
| Income(Loss) | $-46.37MM | $-27.65MM | $-32.39MM |
| Taxes | $0.00MM | $0.54MM | $-0.01MM |
| Profit(Loss) | $-46.37MM | $-28.19MM | $-32.38MM |
| Stockholders Equity | $10.18MM | $5.21MM | $16.06MM |
| Inventory | $0.49MM | $0.95MM | $0.75MM |
| Assets | $16.66MM | $10.74MM | $44.58MM |
| Operating Cash Flow | $-22.28MM | $-22.39MM | $-18.58MM |
| Capital expenditure | $1.02MM | $0.37MM | $0.01MM |
| Investing Cash Flow | $-16.31MM | $-0.24MM | $-0.01MM |
| Financing Cash Flow | $35.95MM | $17.53MM | $15.92MM |
| Earnings Per Share* | $-5,061.14 | $-608.04 | $-108.15 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.